Effects of Intrahypothalamic Administration of microRNA Inhibitors and Mimetics on Blood Plasma Biomarkers in the Rat

P M Masliukov1, V V Porseva2, P A Anfimova2

  • 1Yaroslavl State Medical University, Ministry of Health of the Russian Federation, Yaroslavl, Russia. mpm@ysmu.ru.

PubMed

Insights

MicroRNA mimetics and inhibitors administered to the rat hypothalamus altered age-related changes in C-reactive protein and myoglobin levels. These microRNAs did not affect somatotropic hormone or testosterone.

Area of Science:

  • Molecular biology
  • Neuroendocrinology
  • Aging research

Background:

  • Age-related changes in blood plasma markers are significant.
  • MicroRNAs (miRNAs) play crucial roles in regulating gene expression.
  • The dorsomedial nucleus of the hypothalamus (DMN) is involved in various physiological processes.

Purpose of the Study:

  • To investigate the effect of specific microRNA inhibitors and mimetics on age-related plasma markers.
  • To determine the impact of microRNA modulation in the DMN on C-reactive protein (CRP) and myoglobin levels.
  • To assess the influence of these microRNAs on somatotropic hormone and testosterone in aging rats.

Main Methods:

  • Administration of let-7a-5p, miR-9a-3p, miR-132-3p, and miR-218a-5p microRNA inhibitors and mimetics into the DMN of rats.
  • Comparison of plasma marker levels between young (3-month-old) and aged (24-month-old) control rats.
  • Analysis of plasma C-reactive protein (CRP), myoglobin, somatotropic hormone, and testosterone levels.

Main Results:

  • Aged control rats showed increased CRP and decreased myoglobin compared to young rats.
  • MicroRNA inhibitors exacerbated the age-related increase in CRP and decrease in myoglobin.
  • MicroRNA mimetics reversed these age-related changes in CRP and myoglobin.
  • No significant differences in somatotropic hormone or testosterone were observed across groups or ages.

Conclusions:

  • Specific microRNAs in the DMN can modulate key plasma markers associated with aging.
  • MicroRNA mimetics show potential for counteracting age-related detrimental changes in CRP and myoglobin.
  • The studied microRNAs do not appear to influence somatotropic hormone or testosterone levels in the context of aging.